The Canadian Centre for Vaccinology at Dalhousie University in Halifax says it's 14 participants short to complete a Phase one trial of a made in Canada COVID-19 vaccine candidate. The pharmaceutical company behind the vaccine is hopeful they can find more volunteers to finish the opening phase of the study. Jesse Thomas has more.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting